Indobufen does not usually cause liver function impairment. However, specific medication should be used as prescribed by the doctor. Indobufen belongs to platelet aggregation inhibitors and is suitable for the treatment of ischemic cardiovascular and cerebrovascular lesions caused by atherosclerosis, venous thrombosis, as well as the prevention of thrombosis during hemodialysis. The drug is contraindicated in people who are allergic to the product, pregnant women, lactating women, people with congenital or acquired bleeding disorders, while it is used with caution in people with active lesions of the gastrointestinal tract, people who use non-steroidal anti-inflammatory drugs, elderly patients. After the use of the drug is common dyspepsia, abdominal pain, constipation, nausea, vomiting, headache, dizziness, skin allergic reactions (should be immediately discontinued), epistaxis, gingival bleeding and other adverse reactions, a small number of patients may also have gastric ulcers, gastrointestinal bleeding and hematuria adverse reactions, generally does not cause damage to liver function. However, it is necessary to pay attention to the dosage and course of treatment to avoid overdose and other situations, the specific use of medication should be guided by a specialist, not unauthorized use of medication.